Treco Douglas A
Insider CIK 1688192 · RARX President and CEO, Director · CRSP Director · INZY CEO & Chairman, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-06-05 | 2026-06-09 | 13,000 | — | $0 | 13,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | P Buy | 2025-08-06 | 2025-08-08 | 20,000 | $57.03 | $1.14M | 22,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | D To issuer deriv | 2025-07-01 | 2025-07-03 | 150,000 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | D To issuer deriv | 2025-07-01 | 2025-07-03 | 86,979 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | D To issuer deriv | 2025-07-01 | 2025-07-03 | 400,000 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | U Tender | 2025-07-01 | 2025-07-03 | 43,861 | $4.00 | $175.4K | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award | 2025-06-25 | 2025-06-27 | 2,815 | $0.74 | $2.1K | 43,861 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-06-05 | 2025-06-06 | 13,000 | — | $0 | 13,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | S Sale | 2025-04-02 | 2025-04-03 | 8,819 | $0.89 | $7.8K | 41,046 | SEC↗ |
| INZY Inozyme Pharma, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-03 | 25,000 | — | $0 | 50,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | M Exercise | 2025-04-01 | 2025-04-03 | 25,000 | — | $0 | 49,865 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2025-03-11 | 2025-03-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2025-03-11 | 2025-03-17 | 400,000 | — | $0 | 400,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award | 2024-09-30 | 2024-10-03 | 1,710 | $4.45 | $7.6K | 22,375 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-05-30 | 2024-05-31 | 13,000 | — | $0 | 13,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | S Sale | 2024-04-02 | 2024-04-03 | 7,523 | $6.94 | $52.2K | 20,665 | SEC↗ |
| INZY Inozyme Pharma, Inc. | M Exercise deriv | 2024-04-01 | 2024-04-03 | 25,000 | — | $0 | 75,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | M Exercise | 2024-04-01 | 2024-04-03 | 25,000 | — | $0 | 28,188 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2024-03-13 | 2024-03-15 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2023-06-08 | 2023-06-09 | 13,000 | — | $0 | 13,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2023-04-01 | 2023-04-04 | 800,000 | — | $0 | 800,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2023-04-01 | 2023-04-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2022-06-10 | 2022-06-14 | 9,367 | — | $0 | 9,367 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-06-09 | 2022-06-10 | 12,000 | — | $0 | 12,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2021-06-23 | 2021-06-24 | 9,367 | — | $0 | 9,367 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-06-10 | 2021-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2020-07-23 | 2020-07-24 | 9,367 | — | $0 | 9,367 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-06-11 | 2020-06-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 125,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 139,371 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 241,460 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 164,285 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 20,833 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 311,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 225,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer | 2020-04-02 | 2020-04-03 | 234,707 | $48.00 | $11.27M | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2019-02-01 | 2019-02-05 | 311,000 | — | $0 | 311,000 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-02-01 | 2019-02-05 | 20,834 | — | $0 | 41,666 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | F Tax w/h | 2019-02-01 | 2019-02-05 | 6,327 | $21.00 | $132.9K | 218,799 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-02-01 | 2019-02-05 | 20,834 | — | $0 | 225,126 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 62,500 | — | $0 | 62,500 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2017-02-01 | 2017-02-03 | 225,000 | — | $0 | 225,000 | SEC↗ |